跳转至内容
Merck
CN

341276

抗因子H山羊pAb

liquid, Calbiochem®

登录 查看组织和合同定价。

选择尺寸


关于此项目

NACRES:
NA.43
UNSPSC Code:
12352203
Clone:
polyclonal
Species reactivity:
human
Application:
Citations:
18
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

抗因子H山羊pAb, liquid, Calbiochem®

biological source

goat

antibody form

serum

antibody product type

primary antibodies

clone

polyclonal

form

liquid

contains

≤0.1% sodium azide as preservative

species reactivity

human

manufacturer/tradename

Calbiochem®

availability

not available in Canada

storage condition

OK to freeze
avoid repeated freeze/thaw cycles

dilution

(Radial Immunodiffusion
Ouchterlony (undiluted))

isotype

IgG

shipped in

ambient

storage temp.

−20°C

target post-translational modification

unmodified

Quality Level

Gene Information

human ... CFH(3075)

Application

径向免疫扩散(见备注)

Ouchterlony(≥未稀释)

Disclaimer

毒性:标准处理(A)

General description

兔多克隆抗体以未稀释的血清形式提供。识别因子H。
抗因子H,山羊多克隆,可识别人体内的因子H。它已被验证用于径向免疫扩散和Ouchterlony。
识别因子H。

Immunogen

纯化人因子H

Other Notes

据报道,该抗体还可用于径向免疫扩散。合适的工作稀释度由与测定条件相关的变量决定。

Packaging

请参考特定浓度批号的标签。

Physical form

未稀释的血清。

Preparation Note

初次融化后,等分并冷冻(-20°C)。

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

未找到合适的产品?  

试试我们的产品选型工具.

存储类别

10 - Combustible liquids

wgk

WGK 1


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Martin Ihnatko et al.
Frontiers in medicine, 8, 789972-789972 (2022-01-22)
COVID-19 vaccine-induced thrombotic thrombocytopenia (VITT) is a rare complication of adenoviral vector (ChAdOx1 nCoV-19) vaccine administration. It is presented as thrombocytopenia and thrombotic manifestations in various sites, especially in cerebral veins. Pulmonary emboli have been reported rarely. We present a
Federica Bianchi et al.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 33(11), 12099-12111 (2019-08-24)
The 4 component meningococcus B vaccine (4CMenB) vaccine is the first vaccine containing recombinant proteins licensed for the prevention of invasive meningococcal disease caused by meningococcal serogroup B strains. 4CMenB contains 3 main recombinant proteins, including the Neisseria meningitidis factor
Jingyi Li et al.
Frontiers in immunology, 15, 1368322-1368322 (2024-04-01)
Activation of complement through the alternative pathway (AP) has a key role in the pathogenesis of IgA nephropathy (IgAN). We previously showed, by intraperitoneal injection of Lactobacillus casei cell wall extract (LCWE), C57BL/6 mice develop mild kidney damage in association
Daniele Veggi et al.
PLoS pathogens, 16(10), e1008882-e1008882 (2020-10-03)
Neisseria meningitidis serogroup B (MenB) is the leading cause of meningococcal meningitis and sepsis in industrialized countries, with the highest incidence in infants and adolescents. Two recombinant protein vaccines that protect against MenB are now available (i.e. 4CMenB and MenB-fHbp).
Ashutosh Verma et al.
Infection and immunity, 78(5), 2053-2059 (2010-02-18)
The spirochete Leptospira interrogans is a highly invasive pathogen of worldwide public health importance. Studies from our laboratories and another have demonstrated that L. interrogans can acquire host plasminogen on its surface. Exogenous plasminogen activators can then convert bound plasminogen

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持